Drug Development Solutions

  1. Accelerate Molecules Through Development 3/17/2025

    By leveraging real-time data and operational efficiency, we accelerate timelines — manufacturing and releasing drug products in under seven days and reducing development cycles by up to 12 months.

  2. Comprehensive CGT And Nucleic Acids Analytical Capabilities 9/27/2024

    By leveraging the capabilities of a CDMO, you can focus on the core aspects of your therapy development, confident in the knowledge that your manufacturing and compliance needs are being expertly managed.

  3. Your Partner For Timely, Accurate And High-Quality Preclinical Efficacy Studies 3/27/2025

    By partnering with us, you gain access to cutting-edge facilities and a team of experienced scientists with deep expertise in a wide range of therapeutic areas.

  4. Surfactant Analysis Services

    Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.

  5. Advanced Linker Payload Solutions 7/11/2024

    Our expertise with mAbs and linker technologies ensures the development of ADCs that are not only effective and safe but also tailored to address the specific challenges of targeted therapies.

  6. Simplify Your Linker-Payload Synthesis 4/23/2024

    By streamlining the synthesis pathways, see how these products can effectively diminish the requisite number of developmental and manufacturing stages essential for generating payloads.

  7. Ready To Meet Your Complex OSD Needs, Seamlessly And Simply

    Explore an approach that accelerates your project through key milestones with a technology transfer process that ensures a fast start and process analytical technology that increases efficiency and reduces cost.

  8. Psychedelics: Drug Development Capabilities 10/30/2023

    Learn how harnessing a CDMO’s extensive knowledge and skills in dealing with controlled substances can help you advance your innovative psychedelic therapeutic safely and efficiently.

  9. Peptide Development Strategies 10/27/2022

    Peptides occupy a therapeutic niche between small molecules and large biologics. We understand the fundamental physiological challenges to peptide delivery and that there is no “one-size-fits-all” approach for formulation design.

  10. Designed For Inhalation: Pulmonary And Nasal Delivery

    Our newly expanded in-house capabilities span clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays.